Article ID Journal Published Year Pages File Type
3257329 Clinical Immunology 2011 12 Pages PDF
Abstract
► There are 2 major CD1d-restricted T cell populations ► Both CD1d-restricted T cell subsets can contribute to anti-tumor immunity ► Both CD1d-restricted T cell subsets can “lose” against progressive tumors ► Both CD1d-restricted T cell subsets defects can be reversed ► Improved CD1d-restricted T cell therapies are nearing clinical trials
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , , ,